{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:52:39Z","timestamp":1781736759824,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["OT2HL161847-01"],"award-info":[{"award-number":["OT2HL161847-01"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["RI-CHOP-01-PS10"],"award-info":[{"award-number":["RI-CHOP-01-PS10"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71820-2","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:09:28Z","timestamp":1776438568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection"],"prefix":"10.1038","volume":"17","author":[{"given":"Yuqing","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-2979","authenticated-orcid":false,"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-8074","authenticated-orcid":false,"given":"Michael J.","family":"Becich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2380-4776","authenticated-orcid":false,"given":"Yuriy","family":"Bisyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Blecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Chrischilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri A.","family":"Christakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay G.","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7078-8479","authenticated-orcid":false,"given":"Mollie R.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7848-9781","authenticated-orcid":false,"given":"Soledad A.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy L.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Herring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2656-0263","authenticated-orcid":false,"given":"Benjamin D.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8036-2110","authenticated-orcid":false,"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Mirhaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8956-1466","authenticated-orcid":false,"given":"Abu Saleh Mohammad","family":"Mosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Muszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharine I.","family":"Paules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-201X","authenticated-orcid":false,"given":"Alice I.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden T.","family":"Schwenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumitra","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6414-4172","authenticated-orcid":false,"given":"Bradley W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-4895","authenticated-orcid":false,"given":"David A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9189-9661","authenticated-orcid":false,"given":"Yongqun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-6088","authenticated-orcid":false,"given":"Jeffrey S.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1252-068X","authenticated-orcid":false,"given":"Christopher B.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-0788","authenticated-orcid":false,"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the RECOVER Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"71820_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.7326\/M23-1754","volume":"177","author":"Q Wu","year":"2024","unstructured":"Wu, Q. et al. Real-world effectiveness of BNT162b2 against infection and severe diseases in children and adolescents. Ann. Intern Med. 177, 165\u2013176 (2024).","journal-title":"Ann. Intern Med"},{"key":"71820_CR2","doi-asserted-by":"publisher","first-page":"102962","DOI":"10.1016\/j.eclinm.2024.102962","volume":"79","author":"Q Wu","year":"2025","unstructured":"Wu, Q. et al. Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents. EClinicalMedicine 79, 102962 (2025).","journal-title":"EClinicalMedicine"},{"key":"71820_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal, J. et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) Variant. N. Engl. J. Med. 385, 585\u2013594 (2021).","journal-title":"N. Engl. J. Med."},{"key":"71820_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.2023.27022","volume":"331","author":"LR Feldstein","year":"2024","unstructured":"Feldstein, L. R. et al. Effectiveness of bivalent mRNA COVID-19 vaccines in preventing SARS-CoV-2 infection in children and adolescents aged 5 to 17 years. JAMA 331, 408 (2024).","journal-title":"JAMA"},{"key":"71820_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. N. Engl. J. Med. 386, 1532\u20131546 (2022).","journal-title":"N. Engl. J. Med."},{"key":"71820_CR6","doi-asserted-by":"publisher","unstructured":"Hungerford, D., Cunliffe, N. A. Real world effectiveness of COVID-19 vaccines. BMJ n2034. https:\/\/doi.org\/10.1136\/bmj.n2034 (2021).","DOI":"10.1136\/bmj.n2034"},{"key":"71820_CR7","doi-asserted-by":"publisher","unstructured":"Pilishvili, T. et al. Effectiveness of mRNA Covid-19 vaccine among U.S. Health Care Personnel. New Engl. J. Med. 385 https:\/\/doi.org\/10.1056\/NEJMoa2106599 (2021).","DOI":"10.1056\/NEJMoa2106599"},{"key":"71820_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/jamainternmed.2024.1640","volume":"184","author":"SY Tartof","year":"2024","unstructured":"Tartof, S. Y. et al. Estimated effectiveness of the BNT162b2 XBB vaccine against COVID-19. JAMA Intern Med 184, 932 (2024).","journal-title":"JAMA Intern Med"},{"key":"71820_CR9","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/S1473-3099(23)00746-6","volume":"24","author":"CH Hansen","year":"2024","unstructured":"Hansen, C. H. et al. Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study. Lancet Infect. Dis. 24, e73\u2013e74 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"71820_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38388-7","volume":"14","author":"MD Brannock","year":"2023","unstructured":"Brannock, M. D. et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat. Commun. 14, 2914 (2023).","journal-title":"Nat. Commun."},{"key":"71820_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41109-9","volume":"14","author":"D Mongin","year":"2023","unstructured":"Mongin, D. et al. Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection. Nat. Commun. 14, 5452 (2023).","journal-title":"Nat. Commun."},{"key":"71820_CR12","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMc2205618","volume":"386","author":"C Matuchansky","year":"2022","unstructured":"Matuchansky, C. Protection against SARS-CoV-2 after vaccination and previous infection. N. Engl. J. Med 386, 2534 (2022).","journal-title":"N. Engl. J. Med"},{"key":"71820_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/s41590-023-01613-y","volume":"24","author":"MM Painter","year":"2023","unstructured":"Painter, M. M. et al. Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection. Nat. Immunol. 24, 1711\u20131724 (2023).","journal-title":"Nat. Immunol."},{"key":"71820_CR14","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","volume":"184","author":"A Sokal","year":"2021","unstructured":"Sokal, A. et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell 184, 1201\u20131213.e14 (2021).","journal-title":"Cell"},{"key":"71820_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.7326\/M21-4130","volume":"175","author":"S Gazit","year":"2022","unstructured":"Gazit, S. et al. The incidence of SARS-CoV-2 reinfection in persons with naturally acquired immunity with and without subsequent receipt of a single dose of BNT162b2 vaccine. Ann. Intern Med 175, 674\u2013681 (2022).","journal-title":"Ann. Intern Med"},{"key":"71820_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","volume":"23","author":"N Bobrovitz","year":"2023","unstructured":"Bobrovitz, N. et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect. Dis. 23, 556\u2013567 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"71820_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S2352-4642(23)00101-3","volume":"7","author":"CF Yung","year":"2023","unstructured":"Yung, C. F. et al. BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study. Lancet Child Adolesc. Health 7, 463\u2013470 (2023).","journal-title":"Lancet Child Adolesc. Health"},{"key":"71820_CR18","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2666-5247(23)00103-9","volume":"4","author":"S Gazit","year":"2023","unstructured":"Gazit, S. et al. Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation. Lancet Microbe 4, e495\u2013e505 (2023).","journal-title":"Lancet Microbe"},{"key":"71820_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","volume":"22","author":"A Singanayagam","year":"2022","unstructured":"Singanayagam, A. et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis. 22, 183\u2013195 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"71820_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31838-8","volume":"13","author":"SP Andeweg","year":"2022","unstructured":"Andeweg, S. P. et al. Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections. Nat. Commun. 13, 4738 (2022).","journal-title":"Nat. Commun."},{"key":"71820_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104734","volume":"95","author":"HN Altarawneh","year":"2023","unstructured":"Altarawneh, H. N. et al. Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study. EBioMedicine 95, 104734 (2023).","journal-title":"EBioMedicine"},{"key":"71820_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa2203965","volume":"387","author":"HN Altarawneh","year":"2022","unstructured":"Altarawneh, H. N. et al. Effects of previous infection and vaccination on symptomatic omicron infections. N. Engl. J. Med. 387, 21\u201334 (2022).","journal-title":"N. Engl. J. Med."},{"key":"71820_CR23","doi-asserted-by":"publisher","first-page":"e0299304","DOI":"10.1371\/journal.pone.0299304","volume":"19","author":"S Wu","year":"2024","unstructured":"Wu, S. et al. Protection of prior SARS-CoV-2 infection, COVID-19 boosters, and hybrid immunity against Omicron severe illness: A population-based cohort study of five million residents in Canada. PLoS One 19, e0299304 (2024).","journal-title":"PLoS One"},{"key":"71820_CR24","doi-asserted-by":"publisher","unstructured":"Forrest, C. B., et al. Severity of acute COVID-19 in children <18 years old March 2020 to December 2021. Pediatrics 149 https:\/\/doi.org\/10.1542\/peds.2021-055765 (2022).","DOI":"10.1542\/peds.2021-055765"},{"key":"71820_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45181-7","volume":"15","author":"N Nziza","year":"2024","unstructured":"Nziza, N. et al. Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination. Nat. Commun. 15, 905 (2024).","journal-title":"Nat. Commun."},{"key":"71820_CR26","doi-asserted-by":"crossref","unstructured":"Zhang, B. et al. Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study. Lancet Infectious Dis. 26, 127\u2013138 (2026).","DOI":"10.1016\/S1473-3099(25)00476-1"},{"key":"71820_CR27","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S1473-3099(22)00746-0","volume":"22","author":"The Lancet Infectious Diseases","year":"2022","unstructured":"The Lancet Infectious Diseases Why hybrid immunity is so triggering. Lancet Infect. Dis. 22, 1649 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"71820_CR28","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/infdis\/jiad353","volume":"228","author":"N Lasrado","year":"2023","unstructured":"Lasrado, N. & Barouch, D. H. SARS-CoV-2 hybrid immunity: the best of both worlds. J. Infect. Dis. 228, 1311\u20131313 (2023).","journal-title":"J. Infect. Dis."},{"key":"71820_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106206","volume":"89","author":"R Mikolajczyk","year":"2024","unstructured":"Mikolajczyk, R. et al. Likelihood of post-COVID condition in people with hybrid immunity; data from the German National Cohort (NAKO). J. Infect. 89, 106206 (2024).","journal-title":"J. Infect."},{"key":"71820_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101668","volume":"5","author":"WN Voss","year":"2024","unstructured":"Voss, W. N. et al. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination. Cell Rep. Med 5, 101668 (2024).","journal-title":"Cell Rep. Med"},{"key":"71820_CR31","unstructured":"Zhang, D. et al. Pediatric Gastrointestinal Tract Outcomes During the Postacute Phase of COVID-19. JAMA Network Open 8, e2458366 (2025)."},{"key":"71820_CR32","doi-asserted-by":"crossref","unstructured":"Lu, Y. et al. Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis. Nat. Commun. 16, 6829 (2025).","DOI":"10.1038\/s41467-025-61961-1"},{"key":"71820_CR33","doi-asserted-by":"crossref","unstructured":"Zhang, D. et al. Racial\/ethnic differences in post-acute sequelae of SARS-CoV-2 in children and adolescents in the United States. Nat. Commun. 16, 878 (2025).","DOI":"10.1038\/s41467-024-55273-z"},{"key":"71820_CR34","unstructured":"Li, L et al. Kidney Function Following COVID-19 in Children and Adolescents. JAMA Network Open 8, e254129 (2025)."},{"key":"71820_CR35","doi-asserted-by":"crossref","unstructured":"Zhang, B. et al. Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health records. Nat. Commun. 16, 3445 (2025).","DOI":"10.1038\/s41467-025-56284-0"},{"key":"71820_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00886-0","volume":"9","author":"M Aguilar-Bretones","year":"2024","unstructured":"Aguilar-Bretones, M. et al. SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity. NPJ Vaccines 9, 93 (2024).","journal-title":"NPJ Vaccines"},{"key":"71820_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/EDE.0000000000001562","volume":"34","author":"S Hern\u00e1ndez-D\u00edaz","year":"2023","unstructured":"Hern\u00e1ndez-D\u00edaz, S. et al. Emulating a target trial of interventions initiated during pregnancy with healthcare databases: the example of COVID-19 vaccination. Epidemiology 34, 238\u2013246 (2023).","journal-title":"Epidemiology"},{"key":"71820_CR38","doi-asserted-by":"crossref","unstructured":"Zhou, T. et al. Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults. JAMA Network Open 7, e2441970 (2024).","DOI":"10.1001\/jamanetworkopen.2024.41970"},{"key":"71820_CR39","doi-asserted-by":"crossref","unstructured":"Zhou, T. et al. Pre-COVID-19 body mass index and post-acute\u00a0cardiovascular gastrointestinal and neuropsychiatric outcomes among children and young adults with SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER Initiative. J. Infection 92, 106702 (2026).","DOI":"10.1016\/j.jinf.2026.106702"},{"key":"71820_CR40","doi-asserted-by":"publisher","unstructured":"Lei, Y. et al. Post-Acute Dyslipidemia and Abnormal Body Mass Index in Children and Adolescents with COVID-19: A Cohort Study from the RECOVER Initiative. J. of Pediatrics 291114996 https:\/\/doi.org\/10.1101\/2025.09.17.25336020 (2026).","DOI":"10.1101\/2025.09.17.25336020"},{"key":"71820_CR41","doi-asserted-by":"crossref","unstructured":"Zuo, X., Chen, Y., Ohno-Machado, L. & Xu, H. How do we share data in COVID-19 research? A systematic review of COVID-19 datasets in PubMed Central Articles. Abstract Briefings in Bioinformatics 22, 800\u2013811 (2021).","DOI":"10.1093\/bib\/bbaa331"},{"key":"71820_CR42","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.7326\/M23-1394","volume":"176","author":"GN Ioannou","year":"2023","unstructured":"Ioannou, G. N. et al. Effectiveness of nirmatrelvir\u2013ritonavir against the development of post\u2013COVID-19 conditions among U.S. veterans. Ann. Intern Med 176, 1486\u20131497 (2023).","journal-title":"Ann. Intern Med"},{"key":"71820_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n, M. A. & Robins, J. M. Using big data to emulate a target trial when a randomized trial is not available: Table 1. Am. J. Epidemiol. 183, 758\u2013764 (2016).","journal-title":"Am. J. Epidemiol."},{"key":"71820_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1542\/hpeds.2016-0173","volume":"7","author":"TD Simon","year":"2017","unstructured":"Simon, T. D., Cawthon, M. L., Popalisky, J. & Mangione-Smith, R. Development and validation of the pediatric medical complexity algorithm (PMCA) version 2.0. Hosp. Pediatr. 7, 373\u2013377 (2017).","journal-title":"Hosp. Pediatr."},{"key":"71820_CR45","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin, P. C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat. Med 28, 3083\u20133107 (2009).","journal-title":"Stat. Med"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71820-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:29:20Z","timestamp":1781735360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71820-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71820"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71820-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Horne is a member of the advisory boards of Opsis Health and Lab Me Analytics, a consultant to Pfizer regarding risk scores (funds paid to Intermountain), and an inventor of risk scores licensed by Intermountain to Alluceo and CareCentra. Dr. Horne is site PI of a COVID-19 grant from the Task Force for Global Health, site PI of grants from the Patient-Centered Outcomes Research Institute, a member of the advisory board of Opsis Health, and previously consulted for Pfizer regarding risk scores (funds paid to Intermountain). Dr Jhaveri reported receiving personal fees from the AstraZeneca scientific advisory board, Seqirus scientific advisory board, Sanofi scientific advisory board, and Gilead scientific advisory board; grants from GSK; and an editorial stipend from the Pediatric Infectious Diseases Society for serving as editor-in-chief of the Journal of the Pediatric Infectious Diseases Society outside the submitted work. No other disclosures were reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5372"}}